Court of appeals to decide fate of abortion pill

In this Wednesday, Federal Court of Appeals in New Orleans will listen to arguments in a closely monitored case brought by anti-abortion activists who push for a ban on mifepristone in abortion pillsmost used in the United States.

Biden administration tries to protect mifepristone in the face of growing abortion bans and restrictions imposed in moderate Republican states after the U.S. Supreme Court overturned that ruling in June 2022. Rowe vs. Wade.

Lawyers Mr. Food and Drug Administration (FDA), and the pill maker, Dado Laboratories, will try to convince a three-judge panel of the U.S. Court of Appeals for the Fifth Circuit Don’t restrict access to one of the most popular drugs in decades thousands of American women, according to NBC News.

“Americans Use Mifepristone Safely for over two decades. Over five million women in the United States have used mifepristone to terminate their pregnancies, as have millions of other women worldwide. And study after study shows that serious side effects are extremely rare, ”the FDA presentation says.

Meanwhile, a group of doctors led by the newly formed Hippocratic Medicine Alliance Opponents of abortion claim that the adoption mifepristone FDA in 2000 was “arbitrary” as well as “capricious” therefore it should be withdrawn.

“Plaintiffs’ argument is that the FDA’s decision it was not based on the required scientific evidence. The agency’s position that no court is worthy of reviewing the work of the FDA smacks of arrogance, ”the alliance said.

Management is expected to state that plaintiffs are not entitled to present the case However, because they weren’t hurt by mifepristone’s approval, three of Wednesday’s panel judges are conservatives with a history of opposing abortion rights.

For now, the tablet is available following an emergency order from the U.S. Supreme Court. which suspended the order of conservative and former Christian activist Kaczmarik on appeal.

A few weeks ago, major medical associations, including American College of Obstetricians and Gynecologists (ACOG) And American Medical Association (AMA)said in court documents that removing mifepristone from the market would harm patients by forcing them to undergo more invasive surgical abortions.

Author: Maribel Velasquez
Source: La Opinion

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest